<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04613154</url>
  </required_header>
  <id_info>
    <org_study_id>272919</org_study_id>
    <nct_id>NCT04613154</nct_id>
  </id_info>
  <brief_title>Magnesium as an Adjunct for Pain Treatment After Surgery for Thumb Base Arthrosis</brief_title>
  <official_title>Magnesium as an Adjunct for Pain Treatment After Surgery for Thumb Base Arthrosis, a Randomised Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Region Örebro County</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Region Örebro County</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A randomised controlled trial of addition to the standard pain treatment of 1000 mg oral&#xD;
      magnesium citrate or placebo for 7 Days during surgery for thumb base arthrosis.&#xD;
      Intraoperative nociception will be measured with the NoL-index with a PM-200 machine.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Our hypothesis is that an addition of oral 1000 mg magnesium citrate daily for 7 Days&#xD;
      starting at the day of the surgery will decrease the postoperative pain and improve the&#xD;
      recovery after surgery. It will be given as an supplement to the regular pain treatment with&#xD;
      acetaminophen and oxycodone that are used in our hospital and compared to a placebo. The&#xD;
      choice of treatment will be blinded for the patient, the care providers and for the research&#xD;
      team doing the evaluation.&#xD;
&#xD;
      The pain level will be collected Before surgery, postoperatively and at 14 Days after surgery&#xD;
      and by a self reporting form during the first 7 Days. The patients will also report their&#xD;
      recovery with a modified QoR-15 form. QoR-15 is validated in a Swedish version.&#xD;
&#xD;
      Magnesium is shown to reduce postoperative pain in some studies that used iv magnesium&#xD;
      sulphate. For long lasting pain conditions oral magnesium is shown to improve the patients&#xD;
      well being and decrease their pain in some conditions. Magnesium acts as a mild antagonist at&#xD;
      the NMDA-receptor. Thus low levels of magnesium is thought to increase the risk of long&#xD;
      lasting postoperative pain. Therefore there are reason to expect a higher dose of magnesium&#xD;
      supplement decreases the long lasting post operative pain.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 24, 2020</start_date>
  <completion_date type="Anticipated">January 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>Closed envelope randomisation.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Pain after 48 hours from surgery</measure>
    <time_frame>Self reported at 48 hours after surgery.</time_frame>
    <description>Pain measured with a self reported written numerical rating scale with eleven steps 0-10 where 0 is no pain and 11 is the worst pain possible (NRS) after 48 h after surgery.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>QoR15swe (Quality of Recovery, a 15 item questionaire translated to swedish)</measure>
    <time_frame>Day 1 to day 7 after surgery.</time_frame>
    <description>Recovery measured by QoR15swe day 1-7. A written form filled in by the patients and returned to the hospital by mail. QoR15 is a recovery score with 15 items that gives a score between 0-150. 0 points indicates worst possible recovery and 150 indicates best possible recovery. We are using a swedish translation validated by Lyckner et al 2018.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain 1 hour after surgery</measure>
    <time_frame>1 hour after leaving the operating theatre</time_frame>
    <description>Pain measured with an oral numerical rating scale with eleven steps 0-10 where 0 is no pain and 11 is the worst pain possible (NRS) reported to the staff at the post operative ward 1 hour after surgery.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">56</enrollment>
  <condition>Thumb Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>Magnesium</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Given 1000 mg oral magnesiumcitrate once daily (4*250mg) during the day of surgery and the next 6 Days.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Given placebo once daily during the day of surgery and the next 6 Days.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>magnesiumcitrate</intervention_name>
    <description>Magnesiumcitrate 250 mg, Apoteket AB, Sweden</description>
    <arm_group_label>Magnesium</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Ester-c</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Planned for surgery of thumb base arthrosis with trapeziectomy with ligament&#xD;
             reconstruction tendon interposition.&#xD;
&#xD;
          -  Age 18 years or older.&#xD;
&#xD;
          -  low anesthetic risk, ASA class 1 or 2.&#xD;
&#xD;
          -  Be able to take oral medication.&#xD;
&#xD;
          -  Be able to read and communicate in Swedish.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age under 18 years.&#xD;
&#xD;
          -  Heartfailure, kidney failure, ischemic hearth disease.&#xD;
&#xD;
          -  Previous neuropathic pain or complex pain syndrome.&#xD;
&#xD;
          -  Serious psychiatric morbidity&#xD;
&#xD;
          -  Not able to communicate in Swedish&#xD;
&#xD;
          -  Skin problems that makes the application of NoL-sensor impossible.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pether Jildenstål, phd</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitetssjukhuset Örebro, ANIVA-kliniken</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>John Henriksson, md</last_name>
    <phone>+46196020316</phone>
    <email>john.henriksson@regionorebrolan.se</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marcus Sagerfors, md,phd</last_name>
    <phone>+46196021000</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Örebro University Hospital</name>
      <address>
        <city>Örebro</city>
        <state>Örebro Län</state>
        <zip>701 85</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Forsström, lic. nurse</last_name>
      <phone>019-602 0311</phone>
      <email>maria.forsstrom@regionorebrolan.se</email>
    </contact>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <reference>
    <citation>De Oliveira GS Jr, Castro-Alves LJ, Khan JH, McCarthy RJ. Perioperative systemic magnesium to minimize postoperative pain: a meta-analysis of randomized controlled trials. Anesthesiology. 2013 Jul;119(1):178-90. doi: 10.1097/ALN.0b013e318297630d. Review.</citation>
    <PMID>23669270</PMID>
  </reference>
  <reference>
    <citation>Shin HJ, Na HS, Do SH. Magnesium and Pain. Nutrients. 2020 Jul 23;12(8). pii: E2184. doi: 10.3390/nu12082184. Review.</citation>
    <PMID>32718032</PMID>
  </reference>
  <reference>
    <citation>Cowen R, Stasiowska MK, Laycock H, Bantel C. Assessing pain objectively: the use of physiological markers. Anaesthesia. 2015 Jul;70(7):828-47. doi: 10.1111/anae.13018. Epub 2015 Mar 14. Review.</citation>
    <PMID>25772783</PMID>
  </reference>
  <reference>
    <citation>Brown EN, Pavone KJ, Naranjo M. Multimodal General Anesthesia: Theory and Practice. Anesth Analg. 2018 Nov;127(5):1246-1258. doi: 10.1213/ANE.0000000000003668. Review.</citation>
    <PMID>30252709</PMID>
  </reference>
  <reference>
    <citation>Lyckner S, Böregård IL, Zetterlund EL, Chew MS. Validation of the Swedish version of Quality of Recovery score -15: a multicentre, cohort study. Acta Anaesthesiol Scand. 2018 Aug;62(7):893-902. doi: 10.1111/aas.13086. Epub 2018 Feb 7.</citation>
    <PMID>29417552</PMID>
  </reference>
  <reference>
    <citation>Edry R, Recea V, Dikust Y, Sessler DI. Preliminary Intraoperative Validation of the Nociception Level Index: A Noninvasive Nociception Monitor. Anesthesiology. 2016 Jul;125(1):193-203. doi: 10.1097/ALN.0000000000001130.</citation>
    <PMID>27171828</PMID>
  </reference>
  <reference>
    <citation>Yousef AA, Al-deeb AE. A double-blinded randomised controlled study of the value of sequential intravenous and oral magnesium therapy in patients with chronic low back pain with a neuropathic component. Anaesthesia. 2013 Mar;68(3):260-6. doi: 10.1111/anae.12107. Epub 2012 Dec 17.</citation>
    <PMID>23384256</PMID>
  </reference>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>September 24, 2020</study_first_submitted>
  <study_first_submitted_qc>October 27, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 3, 2020</study_first_posted>
  <last_update_submitted>October 27, 2020</last_update_submitted>
  <last_update_submitted_qc>October 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 3, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

